Drug Shortage Report for AZITHROMYCIN FOR INJECTION USP

Last updated on 2020-04-07 History
Report ID 111093
Drug Identification Number 02483890
Brand name AZITHROMYCIN FOR INJECTION USP
Common or Proper name AZYTHROMYCIN FOR INJECTION USP
Company Name STERIMAX INC
Market Status MARKETED
Active Ingredient(s) AZITHROMYCIN
Strength(s) 500MG
Dosage form(s) POWDER FOR SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 VIALS
ATC code J01FA
ATC description MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS
Reason for shortage Delay in shipping of the drug.
Anticipated start date
Actual start date 2020-03-30
Estimated end date
Actual end date 2020-04-07
Shortage status Resolved
Updated date 2020-04-07
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2770 PORTLAND DRIVE
OAKVILLE, ONTARIO
CANADA L6H 6R4
Company contact information 1-800-881-3550

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2020-04-07 French Compare
v3 2020-04-07 English Compare
v2 2020-04-06 French Compare
v1 2020-04-06 English Compare

Showing 1 to 4 of 4